OraSure Technologies Stock Price, News & Analysis (NASDAQ:OSUR)

$19.81 0.06 (0.30 %)
(As of 01/16/2018 04:42 AM ET)
Previous Close$19.75
Today's Range$19.47 - $19.91
52-Week Range$8.39 - $23.01
Volume352,800 shs
Average Volume582,522 shs
Market Capitalization$1.20 billion
P/E Ratio38.10
Dividend YieldN/A
Beta1.27

About OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies logoOraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. It sells over-the-counter (OTC) cryosurgical products to consumers in North America, Europe, Central and South America, and Australia.

Receive OSUR News and Ratings via Email

Sign-up to receive the latest news and ratings for OSUR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Supplies
SectorHealthcare
SymbolNASDAQ:OSUR
CUSIP68554V10
Phone+1-503-6416115

Debt

Debt-to-Equity RatioN/A
Current Ratio7.86%
Quick Ratio7.23%

Price-To-Earnings

Trailing P/E Ratio38.0961538461538
Forward P/E Ratio46.07
P/E Growth4.44

Sales & Book Value

Annual Sales$128.20 million
Price / Sales9.37
Cash Flow$0.46 per share
Price / Cash43.53
Book Value$3.33 per share
Price / Book5.95

Profitability

Trailing EPS$0.52
Net Income$19.72 million
Net Margins20.48%
Return on Equity14.12%
Return on Assets12.57%

Miscellaneous

Employees325
Outstanding Shares60,650,000

OraSure Technologies (NASDAQ:OSUR) Frequently Asked Questions

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) posted its quarterly earnings results on Wednesday, November, 1st. The medical instruments supplier reported $0.09 EPS for the quarter, hitting the consensus estimate of $0.09. The medical instruments supplier earned $42.30 million during the quarter, compared to analysts' expectations of $40.87 million. OraSure Technologies had a net margin of 20.48% and a return on equity of 14.12%. The firm's revenue was up 31.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.11 EPS. View OraSure Technologies' Earnings History.

When will OraSure Technologies make its next earnings announcement?

OraSure Technologies is scheduled to release their next quarterly earnings announcement on Thursday, February, 8th 2018. View Earnings Estimates for OraSure Technologies.

What guidance has OraSure Technologies issued on next quarter's earnings?

OraSure Technologies updated its fourth quarter earnings guidance on Wednesday, November, 1st. The company provided earnings per share guidance of $0.08-$0.09 for the period, compared to the Thomson Reuters consensus estimate of $0.08. The company issued revenue guidance of $45-$46 million, compared to the consensus revenue estimate of $39.66 million.

Where is OraSure Technologies' stock going? Where will OraSure Technologies' stock price be in 2018?

4 brokers have issued 12-month target prices for OraSure Technologies' stock. Their forecasts range from $11.25 to $23.00. On average, they expect OraSure Technologies' share price to reach $18.81 in the next twelve months. View Analyst Ratings for OraSure Technologies.

Who are some of OraSure Technologies' key competitors?

Who are OraSure Technologies' key executives?

OraSure Technologies' management team includes the folowing people:

  • Stephen S. Tang Ph.D., Chairman of the Board, President, Chief Executive Officer (Age 56)
  • Douglas A. Michels, President, Chief Executive Officer, Director (Age 60)
  • Ronald H. Spair, Chief Financial Officer, Chief Operating Officer, Director (Age 61)
  • Anthony Zezzo II, Executive Vice President - Marketing and Sales (Age 63)
  • Mark L. Kuna, Senior Vice President - Finance, Controller, Assistant Secretary (Age 54)
  • Michael Reed Ph.D., Senior Vice President - Research and Development, Chief Scientific Officer (Age 48)
  • Jack E. Jerrett, Senior Vice President, General Counsel, Secretary (Age 58)
  • Mara Glickman Aspinall, Director (Age 54)
  • Michael Celano, Independent Director (Age 58)
  • Eamonn P. Hobbs, Independent Director (Age 58)

How do I buy OraSure Technologies stock?

Shares of OraSure Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OraSure Technologies' stock price today?

One share of OraSure Technologies stock can currently be purchased for approximately $19.81.

How big of a company is OraSure Technologies?

OraSure Technologies has a market capitalization of $1.20 billion and generates $128.20 million in revenue each year. The medical instruments supplier earns $19.72 million in net income (profit) each year or $0.52 on an earnings per share basis. OraSure Technologies employs 325 workers across the globe.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 150 WEBSTER ST, BETHLEHEM, PA 18015, United States. The medical instruments supplier can be reached via phone at +1-503-6416115 or via email at [email protected]


MarketBeat Community Rating for OraSure Technologies (OSUR)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  307 (Vote Outperform)
Underperform Votes:  138 (Vote Underperform)
Total Votes:  445
MarketBeat's community ratings are surveys of what our community members think about OraSure Technologies and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

OraSure Technologies (NASDAQ:OSUR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.803.002.83
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.81$17.25$16.65$14.38
Price Target Upside: 4.75% downside12.66% downside23.66% downside22.34% downside

OraSure Technologies (NASDAQ:OSUR) Consensus Price Target History

Price Target History for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ:OSUR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/2/2017Jefferies GroupDowngradeBuy -> HoldN/AView Rating Details
9/19/2017Canaccord GenuityReiterated RatingBuy$22.00LowView Rating Details
7/11/2017StephensReiterated RatingOverweight$14.00 -> $19.00LowView Rating Details
2/9/2017Raymond James FinancialUpgradeMarket Perform -> Outperform$11.25N/AView Rating Details
12/20/2016CL KingInitiated CoverageBuy$11.00N/AView Rating Details
9/19/2016BTIG ResearchDowngradeBuy -> Neutral$8.00N/AView Rating Details
7/5/2016MizuhoReiterated RatingOutperform$8.00N/AView Rating Details
(Data available from 1/16/2016 forward)

Earnings

OraSure Technologies (NASDAQ:OSUR) Earnings History and Estimates Chart

Earnings by Quarter for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ OSUR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2018$0.09N/AView Earnings Details
11/1/2017Q3 2017$0.09$0.09$40.87 million$42.30 millionViewN/AView Earnings Details
8/2/2017Q2 2017$0.07$0.09$36.54 million$40.18 millionViewListenView Earnings Details
5/3/2017Q1 2017$0.17$0.21$31.19 million$32.55 millionViewListenView Earnings Details
2/8/2017Q4 2016$0.06$0.13$34.80 million$35.50 millionViewListenView Earnings Details
11/2/2016Q316$0.07$0.11$31.45 million$32.25 millionViewListenView Earnings Details
8/3/2016Q216$0.05$0.07$31.15 million$31.36 millionViewListenView Earnings Details
5/4/2016Q1$0.02$0.04$28.82 million$29.10 millionViewListenView Earnings Details
2/3/2016Q4$0.03$0.08$29.73 million$32.38 millionViewListenView Earnings Details
11/4/2015Q315($0.01)$0.03$29.58 million$29.90 millionViewListenView Earnings Details
8/5/2015Q215$0.01$0.03$28.95 million$30.34 millionViewListenView Earnings Details
2/4/2015Q414($0.04)($0.05)$28.22 million$28.68 millionViewListenView Earnings Details
11/5/2014Q314($0.05)$0.02$27.20 million$27.85 millionViewListenView Earnings Details
8/6/2014Q214($0.04)$0.04$26.21 million$26.40 millionViewListenView Earnings Details
5/7/2014Q114($0.13)($0.10)$23.28 million$23.50 millionViewListenView Earnings Details
2/5/2014Q413($0.08)$0.11$27.43 million$28.80 millionViewListenView Earnings Details
11/6/2013Q313($0.10)($0.03)$24.21 million$24.70 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.16)($0.10)$23.67 million$24.30 millionViewListenView Earnings Details
5/8/2013Q1 2013($0.18)($0.18)$20.82 million$21.20 millionViewListenView Earnings Details
2/6/2013Q4 2012($0.14)($0.11)$20.87 million$22.14 millionViewListenView Earnings Details
11/7/2012Q312($0.07)($0.04)$22.26 million$22.10 millionViewN/AView Earnings Details
8/7/2012($0.08)($0.07)ViewN/AView Earnings Details
5/2/2012($0.09)($0.07)ViewN/AView Earnings Details
2/8/2012Q4 2011($0.07)$0.02ViewN/AView Earnings Details
11/2/2011($0.07)($0.03)ViewN/AView Earnings Details
8/3/2011($0.05)($0.05)ViewN/AView Earnings Details
5/5/2011($0.08)($0.06)ViewN/AView Earnings Details
2/9/2011($0.08)($0.02)ViewN/AView Earnings Details
11/9/2010Q3 2010($0.04)$0.01ViewN/AView Earnings Details
8/4/2010Q2 2010($0.08)($0.01)ViewN/AView Earnings Details
5/5/2010Q1 2010($0.06)($0.05)ViewN/AView Earnings Details
2/10/2010Q4 2009($0.08)($0.03)ViewN/AView Earnings Details
11/4/2009Q3 2009($0.05)$0.04ViewN/AView Earnings Details
8/5/2009Q2 2009($0.07)($0.05)ViewN/AView Earnings Details
5/6/2009Q1 2009($0.07)($0.04)ViewN/AView Earnings Details
2/11/2009Q4 2008($0.10)($0.07)ViewN/AView Earnings Details
11/5/2008Q3 2008($0.11)($0.04)ViewN/AView Earnings Details
8/5/2008Q2 2008($0.08)($0.05)ViewN/AView Earnings Details
5/6/2008Q1 2008$0.03$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

OraSure Technologies (NASDAQ:OSUR) Earnings Estimates

2018 EPS Consensus Estimate: $0.36
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.07$0.07$0.07
Q2 20181$0.09$0.09$0.09
Q3 20181$0.09$0.09$0.09
Q4 20181$0.11$0.11$0.11
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for OraSure Technologies (NASDAQ:OSUR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

OraSure Technologies (NASDAQ OSUR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 6.40%
Institutional Ownership Percentage: 94.43%
Insider Trades by Quarter for OraSure Technologies (NASDAQ:OSUR)
Institutional Ownership by Quarter for OraSure Technologies (NASDAQ:OSUR)

OraSure Technologies (NASDAQ OSUR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/7/2017Mara G AspinallDirectorBuy5,000$14.23$71,150.005,000View SEC Filing  
10/4/2017Douglas A MichelsCEOSell22,923$23.00$527,229.00View SEC Filing  
9/29/2017Douglas A MichelsCEOSell25,000$22.55$563,750.00743,058View SEC Filing  
8/31/2017Brian SmithInsiderSell9,112$20.47$186,522.6432,477View SEC Filing  
8/30/2017Charles W PatrickDirectorSell1,000$20.11$20,110.0051,104View SEC Filing  
8/22/2017Brian SmithInsiderSell3,075$21.09$64,851.7524,540View SEC Filing  
8/7/2017Anthony Zezzo IIEVPSell72,916$21.26$1,550,194.16218,326View SEC Filing  
8/7/2017Jack E JerrettSVPSell73,463$20.77$1,525,826.5181,593View SEC Filing  
8/7/2017Ronald H SpairCFOSell510,112$20.66$10,538,913.92208,606View SEC Filing  
6/27/2017Douglas A MichelsCEOSell290,495$16.75$4,865,791.25894,012View SEC Filing  
5/30/2017Ronny B LancasterDirectorSell89,684$14.79$1,326,426.366,295View SEC Filing  
5/10/2017Anthony Zezzo IIEVPSell115,000$14.70$1,690,500.00260,410View SEC Filing  
5/9/2017Douglas A MichelsCEOSell209,800$15.01$3,149,098.00782,025View SEC Filing  
5/8/2017Douglas A MichelsCEOSell361,216$15.08$5,447,137.28881,620View SEC Filing  
5/8/2017Mark L KunaSVPSell36,413$15.11$550,200.4392,904View SEC Filing  
5/8/2017Ronald H SpairCFOSell72,564$15.00$1,088,460.00175,130View SEC Filing  
5/5/2017Michael CelanoDirectorSell44,962$14.95$672,181.9038,117View SEC Filing  
3/21/2017Stephen S Phd TangDirectorSell220$12.00$2,640.0031,748View SEC Filing  
2/28/2017Charles W PatrickDirectorSell29,883$11.29$337,379.0774,959View SEC Filing  
2/16/2017Ronald H SpairCFOSell50,000$11.12$556,000.00View SEC Filing  
2/15/2017Jack E JerrettSVPSell107,288$11.06$1,186,605.2880,842View SEC Filing  
2/15/2017Stephen S Phd TangDirectorSell40,000$11.04$441,600.0078,068View SEC Filing  
2/14/2017Ronald H SpairCFOSell63,720$10.60$675,432.00169,860View SEC Filing  
2/10/2017Mark L KunaSVPSell79,271$10.61$841,065.3163,491View SEC Filing  
1/31/2017Michael CelanoDirectorSell15,000$8.78$131,700.00108,079View SEC Filing  
1/17/2017Ronald H SpairCFOSell3,341$8.71$29,100.11106,663View SEC Filing  
12/15/2016Mark L KunaSVPSell10,000$9.30$93,000.0082,965View SEC Filing  
12/13/2016Douglas A MichelsCEOSell71,466$9.07$648,196.62747,114View SEC Filing  
12/13/2016Mark L KunaSVPSell17,000$9.11$154,870.0084,965View SEC Filing  
12/9/2016Mark L KunaSVPSell3,000$9.03$27,090.0075,965View SEC Filing  
11/23/2016Douglas A MichelsCEOSell30,893$9.02$278,654.86731,898View SEC Filing  
11/23/2016Jack E JerrettSVPSell24,000$9.00$216,000.0060,105View SEC Filing  
9/26/2016Douglas A MichelsCEOSell25,000$8.22$205,500.00756,898View SEC Filing  
8/31/2016Charles W PatrickDirectorSell17,483$8.58$150,004.1477,209View SEC Filing  
8/30/2016Jack E JerrettSVPSell68,686$8.52$585,204.7286,441View SEC Filing  
8/29/2016Charles W PatrickDirectorSell2,250$8.94$20,115.0077,209View SEC Filing  
8/5/2016Charles W PatrickDirectorSell6,575$7.24$47,603.0077,209View SEC Filing  
12/19/2014Ronald H SpairCFOSell75,974$10.01$760,499.74View SEC Filing  
12/9/2014Ronald H SpairCFOSell1,026$10.00$10,260.00View SEC Filing  
12/8/2014Ronald H SpairCFOSell126$10.00$1,260.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

OraSure Technologies (NASDAQ OSUR) News Headlines

Source:
DateHeadline
$47.97 Million in Sales Expected for OraSure Technologies, Inc. (OSUR) This Quarter$47.97 Million in Sales Expected for OraSure Technologies, Inc. (OSUR) This Quarter
www.americanbankingnews.com - January 14 at 4:30 AM
OraSure Technologies (OSUR) Rating Increased to Hold at Zacks Investment ResearchOraSure Technologies (OSUR) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - January 9 at 9:02 AM
OraSure Technologies, Inc. (OSUR) Receives Average Rating of "Buy" from AnalystsOraSure Technologies, Inc. (OSUR) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - January 8 at 3:38 PM
Why OraSure Technologies, Inc. Rallied 10.8% in DecemberWhy OraSure Technologies, Inc. Rallied 10.8% in December
finance.yahoo.com - January 6 at 10:11 AM
OraSure Technologies to Present at the 36th Annual JP Morgan Healthcare Conference - NasdaqOraSure Technologies to Present at the 36th Annual JP Morgan Healthcare Conference - Nasdaq
www.nasdaq.com - January 5 at 10:24 AM
OraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare ConferenceOraSure Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference
feeds.benzinga.com - January 5 at 7:25 AM
OraSure Technologies (OSUR) Boosts 4Q Revenue Guidance; Announces CEO & CFO Succession Plans - StreetInsider.comOraSure Technologies (OSUR) Boosts 4Q Revenue Guidance; Announces CEO & CFO Succession Plans - StreetInsider.com
www.streetinsider.com - January 4 at 10:09 AM
OraSure Technologies Announces Management Succession PlanOraSure Technologies Announces Management Succession Plan
finance.yahoo.com - January 4 at 10:09 AM
University City Science Center CEO stepping downUniversity City Science Center CEO stepping down
finance.yahoo.com - January 4 at 10:09 AM
Recro Pharma Announces Key Executive Promotions to the Financial TeamRecro Pharma Announces Key Executive Promotions to the Financial Team
finance.yahoo.com - January 3 at 9:31 AM
OraSure Technologies (OSUR) Upgraded at Zacks Investment ResearchOraSure Technologies (OSUR) Upgraded at Zacks Investment Research
www.americanbankingnews.com - December 30 at 6:14 AM
OraSure Technologies, Inc. (OSUR) Expected to Post Quarterly Sales of $45.27 MillionOraSure Technologies, Inc. (OSUR) Expected to Post Quarterly Sales of $45.27 Million
www.americanbankingnews.com - December 29 at 8:54 PM
ETFs with exposure to OraSure Technologies, Inc. : December 27, 2017ETFs with exposure to OraSure Technologies, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 2:36 PM
$0.09 EPS Expected for OraSure Technologies, Inc. (OSUR) This Quarter$0.09 EPS Expected for OraSure Technologies, Inc. (OSUR) This Quarter
www.americanbankingnews.com - December 27 at 7:28 AM
OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 10:10 AM
Steris (STE) vs. OraSure Technologies (OSUR) Financial ContrastSteris (STE) vs. OraSure Technologies (OSUR) Financial Contrast
www.americanbankingnews.com - December 24 at 1:31 AM
OraSure Technologies (OSUR) Lifted to Buy at BidaskClubOraSure Technologies (OSUR) Lifted to Buy at BidaskClub
www.americanbankingnews.com - December 21 at 10:02 PM
Head to Head Review: OraSure Technologies (OSUR) versus Sientra (SIEN)Head to Head Review: OraSure Technologies (OSUR) versus Sientra (SIEN)
www.americanbankingnews.com - December 14 at 11:04 PM
OraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by AnalystsOraSure Technologies, Inc. (OSUR) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - December 14 at 8:28 PM
Quotidian Technical Highlights on Selected Medical Supplies Stocks ... - PR Newswire (press release)Quotidian Technical Highlights on Selected Medical Supplies Stocks ... - PR Newswire (press release)
www.prnewswire.com - December 12 at 4:59 PM
Quotidian Technical Highlights on Selected Medical Supplies Stocks -- OraSure Technologies, Hill-Rom, Tandem Diabetes Care, and Mazor RoboticsQuotidian Technical Highlights on Selected Medical Supplies Stocks -- OraSure Technologies, Hill-Rom, Tandem Diabetes Care, and Mazor Robotics
www.bizjournals.com - December 12 at 10:41 AM
Zacks: Analysts Anticipate OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $45.27 MillionZacks: Analysts Anticipate OraSure Technologies, Inc. (OSUR) Will Post Quarterly Sales of $45.27 Million
www.americanbankingnews.com - December 11 at 4:32 AM
OraSure Technologies Announces 2018 Annual Meeting Date - GlobeNewswire (press release)OraSure Technologies Announces 2018 Annual Meeting Date - GlobeNewswire (press release)
globenewswire.com - December 8 at 10:13 AM
OraSure Technologies (OSUR) Lifted to "Hold" at Zacks Investment ResearchOraSure Technologies (OSUR) Lifted to "Hold" at Zacks Investment Research
www.americanbankingnews.com - December 2 at 7:24 AM
AtriCure (ATRC) versus OraSure Technologies (OSUR) Head-To-Head SurveyAtriCure (ATRC) versus OraSure Technologies (OSUR) Head-To-Head Survey
www.americanbankingnews.com - December 1 at 11:38 AM
OraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV TestingOraSure Technologies Supports World AIDS Day With Innovative Programs to Enable HIV Testing
finance.yahoo.com - November 30 at 4:39 PM
OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell in Honor of World AIDS Day - GlobeNewswire (press release)OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell in Honor of World AIDS Day - GlobeNewswire (press release)
globenewswire.com - November 30 at 10:52 AM
OraSure Technologies, Inc. (OSUR) Short Interest Down 71.2% in NovemberOraSure Technologies, Inc. (OSUR) Short Interest Down 71.2% in November
www.americanbankingnews.com - November 28 at 2:38 AM
OraSure Technologies Target of Unusually Large Options Trading (OSUR)OraSure Technologies Target of Unusually Large Options Trading (OSUR)
www.americanbankingnews.com - November 25 at 1:02 AM
OraSure Technologies IncOraSure Technologies Inc
www.bloomberg.com - November 23 at 7:16 AM
OraSure Technologies (OSUR) Subsidiary Enters $143M Supply Deal for Oragene DxOraSure Technologies (OSUR) Subsidiary Enters $143M Supply Deal for Oragene Dx
www.streetinsider.com - November 23 at 7:16 AM
Today’s Research Reports on Stocks to Watch: Medtronic and Orasure TechnologiesToday’s Research Reports on Stocks to Watch: Medtronic and Orasure Technologies
finance.yahoo.com - November 23 at 7:16 AM
OraSure Technologies, Inc.: Fading performance but may be making a comeback?OraSure Technologies, Inc.: Fading performance but may be making a comeback?
finance.yahoo.com - November 23 at 7:16 AM
Zacks: Brokerages Anticipate OraSure Technologies, Inc. (OSUR) Will Announce Quarterly Sales of $45.27 MillionZacks: Brokerages Anticipate OraSure Technologies, Inc. (OSUR) Will Announce Quarterly Sales of $45.27 Million
www.americanbankingnews.com - November 23 at 6:52 AM
OraSure Technologies (OSUR) PT Raised to $21 at Canaccord Genuity on New $143M Contract; Direct-to-Consumer ... - StreetInsider.comOraSure Technologies (OSUR) PT Raised to $21 at Canaccord Genuity on New $143M Contract; 'Direct-to-Consumer ... - StreetInsider.com
www.streetinsider.com - November 22 at 6:31 AM
Why OraSure Technologies, Inc. Zoomed Higher TodayWhy OraSure Technologies, Inc. Zoomed Higher Today
finance.yahoo.com - November 22 at 6:31 AM
Zacks: Brokerages Expect OraSure Technologies, Inc. (OSUR) Will Announce Earnings of $0.09 Per ShareZacks: Brokerages Expect OraSure Technologies, Inc. (OSUR) Will Announce Earnings of $0.09 Per Share
www.americanbankingnews.com - November 21 at 7:28 PM
OraSure Technologies, Inc. (OSUR) Given Average Rating of "Buy" by BrokeragesOraSure Technologies, Inc. (OSUR) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - November 19 at 3:48 PM
Meridian Bioscience (VIVO) & OraSure Technologies (OSUR) Financial AnalysisMeridian Bioscience (VIVO) & OraSure Technologies (OSUR) Financial Analysis
www.americanbankingnews.com - November 15 at 3:30 PM
OraSure Technologies, Inc. (OSUR) Director Purchases $71,150.00 in StockOraSure Technologies, Inc. (OSUR) Director Purchases $71,150.00 in Stock
www.americanbankingnews.com - November 9 at 7:50 PM
Stocks To Watch: Orasure Technologies Sees Relative Strength Rating Jump To 83Stocks To Watch: Orasure Technologies Sees Relative Strength Rating Jump To 83
finance.yahoo.com - November 7 at 8:23 AM
FY2017 EPS Estimates for OraSure Technologies, Inc. Lowered by Jefferies Group (OSUR)FY2017 EPS Estimates for OraSure Technologies, Inc. Lowered by Jefferies Group (OSUR)
www.americanbankingnews.com - November 6 at 3:28 AM
Is This Why OraSure Technologies, Inc. Is Tanking Today? - Motley FoolIs This Why OraSure Technologies, Inc. Is Tanking Today? - Motley Fool
www.fool.com - November 4 at 9:20 PM
Zacks Investment Research Downgrades OraSure Technologies, Inc. (OSUR) to HoldZacks Investment Research Downgrades OraSure Technologies, Inc. (OSUR) to Hold
www.americanbankingnews.com - November 4 at 10:37 AM
ValuEngine Downgrades OraSure Technologies, Inc. (OSUR) to HoldValuEngine Downgrades OraSure Technologies, Inc. (OSUR) to Hold
www.americanbankingnews.com - November 3 at 12:14 AM
Is This Why OraSure Technologies, Inc. Is Tanking Today?Is This Why OraSure Technologies, Inc. Is Tanking Today?
www.fool.com - November 2 at 3:25 PM
OraSure Technologies, Inc. (OSUR) Posts Quarterly  Earnings ResultsOraSure Technologies, Inc. (OSUR) Posts Quarterly Earnings Results
www.americanbankingnews.com - November 2 at 2:36 PM
OraSure Technologies, Inc. to Host Earnings CallOraSure Technologies, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 7:25 AM
OraSure Announces 2017 Third Quarter Financial ResultsOraSure Announces 2017 Third Quarter Financial Results
finance.yahoo.com - November 2 at 7:25 AM
OraSure meets 3Q profit forecastsOraSure meets 3Q profit forecasts
finance.yahoo.com - November 2 at 7:25 AM

SEC Filings

OraSure Technologies (NASDAQ:OSUR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

OraSure Technologies (NASDAQ:OSUR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

OraSure Technologies (NASDAQ OSUR) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.